Pleural Mesothelioma: An Institutional Experience of 66 Cases
3
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Background: Malignant mesothelioma of the pleura is an aggressive tumor known to be associated with asbestos. Histological diagnosis of mesothelioma is challenging and is usually aided by immunohistochemical markers. Methods: During an 18-year period (1995-2012), 66 patients with pleural mesothelioma were diagnosed at the Samsung Medical Center in Seoul. We reviewed hematoxylin and eosin and immunohistochemical slides of pleural mesothelioma and evaluated their pathological and clinical features. Results: The male-to-female ratio was 1.75:1, and age of patients ranged from 28 to 80 years with an average age of 56.84 years. Twenty-two out of 66 patients underwent curative pneumonectomy. Follow-up data was available in 60 patients (90.9%), and 50 of them (83.3%) died from the disease. The average overall survival was 15.39 months. Histologically, the epithelioid type was the most common, followed by the sarcomatoid and the biphasic types. Epidemiologic information was not available in most cases, and only one patient was confirmed to have a history of asbestos exposure. Conclusions: Malignant mesothelioma of the pleura is a fatal tumor, and the therapeutic benefit of pneumonectomy remains unproven. The combination of calretinin, Wilms tumor 1, HMBE-1, and thyroid transcription factor-1 may provide high diagnostic accuracy in diagnosing mesothelioma.
Abstract
Background: Malignant mesothelioma of the pleura is an aggressive tumor known to be associated with asbestos. Histological diagnosis of mesothelioma is challenging and is usually aided by immunohistochemical markers. Methods: During an 18-year period (1995-2012), 66 patients with pleural mesothelioma were diagnosed at the Samsung Medical Center in Seoul. We reviewed hematoxylin and eosin and immunohistochemical slides of pleural mesothelioma and evaluated their pathological and clinical features. Results: The male-to-female ratio was 1.75:1, and age of patients ranged from 28 to 80 years with an average age of 56.84 years. Twenty-two out of 66 patients underwent curative pneumonectomy. Follow-up data was available in 60 patients (90.9%), and 50 of them (83.3%) died from the disease. The average overall survival was 15.39 months. Histologically, the epithelioid type was the most common, followed by the sarcomatoid and the biphasic types. Epidemiologic information was not available in most cases, and only one patient was confirmed to have a history of asbestos exposure. Conclusions: Malignant mesothelioma of the pleura is a fatal tumor, and the therapeutic benefit of pneumonectomy remains unproven. The combination of calretinin, Wilms tumor 1, HMBE-1, and thyroid transcription factor-1 may provide high diagnostic accuracy in diagnosing mesothelioma.
참고문헌 (25)
- Robinson BW, "Advances in malignant mesothelioma", N Engl J Med, 353, pp.1591~1603 (2005)
- Aigner C, "Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma", Eur J Cardiothorac Surg, 34, pp.204~207 (2008)
- Ceresoli GL, "Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma", Lung Cancer, 34, pp.279~287 (2001)
- Sugarbaker DJ, "Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients", Ann Surg, 224, pp.288~294 (1996)
- Takagi K, "Surgical approach to pleural diffuse mesothelioma in Japan", Lung Cancer, 31, pp.57~65 (2001)
- Husain AN, "Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group", Arch Pathol Lab Med, 137, pp.647~667 (2013)
- Addis B, "Problems in mesothelioma diagnosis", Histopathology, 54, pp.55~68 (2009)
- Abutaily AS, "Immunohistochemistry in the distinction between malignant mesothelioma and pulmonary adenocarcinoma: a critical evaluation of new antibodies", J Clin Pathol, 55, pp.662~668 (2002)
- Ordóñez NG, "Immunohistochemical diagnosis of epithelioid mesothelioma: an update", Arch Pathol Lab Med, 129, pp.1407~1414 (2005)
- 정순희, "악성중피종의 병리학적 진단", 대한의사협회지, 52(5), pp.456~464 (2009), 대한의사협회
- Travis WD, "Pathology and genetics of tumours of the lung, pleura, thymus and heart" (2004), IARC Press
- Mocanu L, "Value of antimesothelioma HBME-1 in the diagnosis of inflammatory and malignant pleural effusions", Rom J Morphol Embryol, 47, pp.351~355 (2006)
- Oates J, "HBME-1, MOC-31, WT1 and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma", Histopathology, 36, pp.341~347 (2000)
- Attanoos RL, "The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium: a novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2", Histopathology, 43, pp.231~238 (2003)
- Johansson L, "Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas", Chest, 109, pp.109~114 (1996)
- Ordóñez NG, "Deciduoid mesothelioma: report of 21 cases with review of the literature", Mod Pathol, 25, pp.1481~1495 (2012)
- Waller DA, "Malignant mesothelioma: British surgical strategies", Lung Cancer, 45(Suppl 1), pp.S81~S84 (2004)
- Stewart DJ, "The effect of extent of local resection on patterns of disease progression in malignant pleural mesothelioma", Ann Thorac Surg, 78, pp.245~252 (2004)
- Janne PA, "Chemotherapy for malignant pleural mesothelioma", Clin Lung Cancer, 5, pp.98~106 (2003)
- Bagheri R, "Malignant pleural mesothelioma: clinicopathologic and survival characteristic in a consecutive series of 40 patients", Ann Thorac Cardiovasc Surg, 17, pp.130~136 (2011)
- 김형렬, "Overview of Asbestos Issues in Korea", Journal of Korean Medical Science, 24(3), pp.363~367 (2009), 대한의학회
- 김형렬, "국내 악성중피종 발생의 역학적 특성", 대한의사협회지, 52(5), pp.449~455 (2009), 대한의사협회
- 정순희, "A decade of malignant mesothelioma surveillance in Korea", AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 55(10), pp.869~875 (2012), WILEY-LISS
- 강동묵, "석면과 환경성질환", 대한의사협회지, 55(3), pp.214~222 (2012), 대한의사협회
- 엄민섭, "No Detection of Simian Virus 40 in Malignant Mesothelioma in Korea", Journal of Pathology and Translational Medicine, 47(2), pp.124~129 (2013), 대한병리학회[DOI]